Skye Bioscience SKYE
NASDAQ SKYE
$1.63 +0.01 (+0.62%)
At close: Oct 21, 2026 · 4:00 PM EDT

Skye Bioscience (SKYE) Long-Term Debt Repayments (2013 - 2026)

Updated

Skye Bioscience (SKYE) recorded Long-Term Debt Repayments of $107,288 in Q2 2026, up 50.0% from the prior quarter.

Analysis

Skye Bioscience (SKYE) Long-Term Debt Repayments (2013 - 2026) Analysis & Trends

On a TTM basis, Skye Bioscience's Long-Term Debt Repayments came in at $178,813 as of Jun 30, 2026, up 996.6% year-over-year; for FY2023, it was $259,335, down 5.9% from FY2022.

  • Across earlier years, Long-Term Debt Repayments came in at $275,537 in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Repayment (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 873.00 Mn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 1.00 Mn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 2.00 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 5.00 Mn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 20.00 Mn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 2.46 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 17.00 Mn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -
10 Skye Bioscience 7.90 Mn -80.32 Mn - 107,288.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 107,288.00
Mar 31, 2026 71,525.00
Oct 31, 2013 4,423.00
API Access

Skye Bioscience Long-Term Debt Repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=SKYE&period=max&api_key=YOUR_API_KEY